Bcl-2 gene therapy (Selective Genetics)

N/A

Report date: 2025/03/18 20:00:05

Base Information

Drug NameBcl-2 gene therapy (Selective Genetics)
Drug Alias Nametissue repair therapy (Selective Genetics)
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionApoptosis regulator Bcl-2 modulators
TargetsApoptosis regulator Bcl-2
Therapy Area/IndicationsWounds and InjuriesIschemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSelective Genetics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSelective Genetics Inc
Active IndicationsN/A
Inactive IndicationsWounds and InjuriesIschemia

Other Information

ATC CodeN/A
Related LinksN/A